These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 4464666)
21. [Correction of hyperlipidemia with Allicor]. Andrianova IV; Demidova OM; Medvedeva LA; Latyshev OA Klin Med (Mosk); 2004; 82(4):56-8. PubMed ID: 15164512 [TBL] [Abstract][Full Text] [Related]
22. [Therapy of hypercholesterolemia with particular reference to inhibitors of cholesterol synthesis]. Guarini G; Vitaliano E Clin Ter; 1988 May; 125(4):271-5. PubMed ID: 2974362 [No Abstract] [Full Text] [Related]
23. Report on a double-blind investigation into the influence of -pyridyl-carbinol on the cholesterol level of the blood. Nelemans FA Arzneimittelforschung; 1972 Aug; 22(8):1410-3. PubMed ID: 4564745 [No Abstract] [Full Text] [Related]
26. [The effects of plasma cholesterol reduction on vasoconstriction due to sympathetic activation in patients with moderate primary hypercholesterolemia]. Pompeo F; De Luca N; Iovino G; Marchegiano R; Gisonni P; Fontana D; Del Mirto C; Trimarco B Minerva Med; 1994 Apr; 85(4):173-8. PubMed ID: 8028744 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness of ezetimibe in clinical practice. Jurado J; Seip R; Thompson PD Am J Cardiol; 2004 Mar; 93(5):641-3. PubMed ID: 14996600 [TBL] [Abstract][Full Text] [Related]
28. A need to redefine the consensus on the use of statins in coronary heart disease prevention. Fruchart JC Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008 [No Abstract] [Full Text] [Related]
29. [Effect of enduracin on the activity of a cholesterol ester transfer protein in blood plasma of people with hypercholesteremia]. Gorshkova IN; Kiseleva NG; Akhmedzhanov NM; Perova NV Biull Eksp Biol Med; 1996 Feb; 121(2):185-7. PubMed ID: 9026127 [No Abstract] [Full Text] [Related]
30. [The cholesterol hypothesis has been proved true at last]. Huttunen J Duodecim; 1995; 111(5):385-6. PubMed ID: 8674438 [No Abstract] [Full Text] [Related]
31. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Bruckert E; Giral P; Tellier P Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406 [No Abstract] [Full Text] [Related]
32. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia. Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666 [No Abstract] [Full Text] [Related]
33. The effect of clofibrate on raised serum lipid levels. Smith RB; Prior IA; Cooke NJ N Z Med J; 1968 Oct; 68(437):231-4. PubMed ID: 5247681 [No Abstract] [Full Text] [Related]
34. Experience with statin use in patients with chronic hepatitis C infection. Gibson K; Rindone JP Am J Cardiol; 2005 Nov; 96(9):1278-9. PubMed ID: 16253597 [TBL] [Abstract][Full Text] [Related]
35. [Cholesterol values of an elderly person]. Viikari J Duodecim; 2002; 118(3):217-9. PubMed ID: 12233021 [No Abstract] [Full Text] [Related]
36. [Drugs active on blood cholesterol]. Jaillard J; Sezille G Med Chir Dig; 1978; 7(2):163-7. PubMed ID: 661413 [No Abstract] [Full Text] [Related]
37. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare? Gotto AM; Kuller LH Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688 [No Abstract] [Full Text] [Related]
38. [Statins-a panacea?]. Klose G Z Kardiol; 2004; 93 Suppl 1():I19-22. PubMed ID: 15022003 [TBL] [Abstract][Full Text] [Related]
39. Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic. O'Donnell DC; Chen NT; Piziak VK Am J Health Syst Pharm; 2001 Feb; 58(4):325-30. PubMed ID: 11225170 [No Abstract] [Full Text] [Related]